Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

被引:0
|
作者
Mushtaq, Muhammad Umair [1 ,2 ]
Chaudhary, Sibgha Gull [1 ,2 ]
Michaelis, Laura C. [3 ]
Carlson, Karen-Sue B. [3 ]
Abedin, Sameem [3 ]
Runass, Lyndsey [3 ]
Fallon, Michael J. [1 ,2 ]
Harrington, Alexandra M. [4 ]
Juckett, Mark [2 ,5 ]
Hall, Aric C. [1 ,2 ]
Mattison, Ryan J. [1 ,2 ]
Atallah, Ehab L. [3 ]
Murthy, Guru Subramanian Guru [3 ]
机构
[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Hematol Oncol, Madison, WI USA
[2] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[3] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA
[5] Univ Wisconsin, Sch Med & Publ Hlth, Div Hematol Oncol, Madison, WI USA
关键词
D O I
10.1182/blood-2018-99-113764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2708
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia
    Reid, Justin H.
    Marini, Bernard L.
    Benitez, Lydia L.
    Pettit, Kristen
    Bixby, Dale L.
    Burke, Patrick
    Perissinotti, Anthony J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 393 - +
  • [2] Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
    Mushtaq, Muhammad Umair
    Harrington, Alexandra M.
    Chaudhary, Sibgha Gull
    Michaelis, Laura C.
    Carlson, Karen-Sue B.
    Abedin, Sameem
    Runass, Lyndsey
    Callander, Natalie S.
    Fallon, Michael J.
    Juckett, Mark
    Hall, Aric C.
    Hematti, Peiman
    Mattison, Ryan J.
    Atallan, Ehab L.
    Murthy, Guru Subramanian Guru
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 158 - 166
  • [3] OUTCOMES OF SALVAGE CHEMOTHERAPY REGIMENS IN CHILDREN AND ADOLESCENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Tak, Himangi
    Trivedi, Maharshi
    Joshi, Nitin
    Panchal, Harsha
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S553 - S553
  • [4] Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia
    M B Thomas
    C Koller
    Y Yang
    Y Shen
    S O'Brien
    H Kantarjian
    J Davis
    E Estey
    Leukemia, 2003, 17 : 990 - 993
  • [5] Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia
    Thomas, MM
    Koller, C
    Yang, Y
    Shen, Y
    O'Brien, S
    Kantarjian, H
    Davis, J
    Estey, E
    LEUKEMIA, 2003, 17 (05) : 990 - 993
  • [6] Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
    Bogdan Popescu
    Sheenu Sheela
    Julie Thompson
    Sophia Grasmeder
    Therese Intrater
    Christin B. DeStefano
    Christopher S. Hourigan
    Catherine Lai
    Clinical Hematology International, 2020, 2 (1) : 27 - 31
  • [7] Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia A retrospective cohort study
    Xu, Jun
    Lv, Ting-Ting
    Zhou, Xiao-Fen
    Huang, Ying
    Liu, Dong-Dong
    Yuan, Guo-Lin
    MEDICINE, 2018, 97 (39)
  • [8] Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia (AML).
    Thomas, M
    Koller, C
    Yang, Y
    Shen, Y
    O'Brien, S
    Kantarjian, H
    Davis, J
    Estey, E
    BLOOD, 2001, 98 (11) : 224B - 224B
  • [9] Salvage therapy for relapsed or refractory acute myeloid leukemia
    Mangan, James K.
    Luger, Selina M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (02) : 73 - 82
  • [10] Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia
    Ochs, Madeleine A.
    Marini, Bernard L.
    Benitez, Lydia L.
    Stump, Sarah E.
    Weis, Taylor M.
    Buhlinger, Kaitlyn M.
    Diaz, Thomas
    Reid, Justin H.
    Muluneh, Benyam
    Pettit, Kristen
    Burke, Patrick
    Bixby, Dale L.
    Perissinotti, Anthony J.
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 1839 - 1848